Ari M. Melnick, MD, is the Gebroe Family Professor of Hematology/Oncology in the Departments of Medicine and Pharmacology at the Weill Cornell Medical College in NewYork City. He received his doctorate in Medicine from the University of Buenos Aires in Argentina, and completed a residency in internal medicine and a fellowship in hematology/oncology at the Mount Sinai School of Medicine in New York City. Dr. Melnick then did a post-doctoral fellowship with Dr. Jonathan Licht at Mount Sinai on the topic of transcriptional regulation in leukemia. Dr. Melnick started his independent laboratory at the Albert Einstein College of Medicine, and then moved to Weill Cornell in 2008.
Dr. Melnick is director of the Sackler Center for Biomedical and Physical Sciences at Weill Cornell, and co-leader of the New York Leukemia Working Group. He has been Scientific Chair of the American Society of Hematology Annual Meeting, and has organized several meetings in the areas of epigenetics and hematologic malignancies. He has authored or co-authored more than 125 published manuscripts in journals such as Nature, Science, Cell, Cancer Cell, Nature Medicine, Nature Immunology and the New England Journal of Medicine. His research interests include the biology and molecular targeting of B-cell lymphomas, targeting transcriptional and epigenetic repressors for cancer therapy, and identifying the epigenetic basis of hematologic malignancies.
Dr. Melnick is especially interested in mentoring trainees and developing programs for career development of junior scientists. He was director of the Mount Sinai School of Medicine Fellowship program and the Weill Cornell Research Track Residency Program. He has worked for many years at the national level to develop educational curricula, training awards, and new training opportunities for junior scientists.